A Study to Assess the Efficacy of Rucaparib in Metastatic Breast Cancer Patients With a BRCAness Genomic Signature
Clinical trial NCT02505048 · COMPLETED
Trial details
- NCT number
- NCT02505048
- Sponsor
- UNICANCER
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-01
- Primary completion
- 2019-02-01
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.